Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.56B |
| 2 |
AT&T
T
|
+$797M |
| 3 |
Pfizer
PFE
|
+$786M |
| 4 |
FON
SPRINT CORP FON COM
FON
|
+$724M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$672M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 4.53% |
| 2 | Financials | 4.48% |
| 3 | Technology | 4% |
| 4 | Communication Services | 3.52% |
| 5 | Energy | 3.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WFM
876
CALL
DELISTED
Whole Foods Market Inc
WFM
| $13.1M | 0.02% |
+254,200
| New | +$12.3M |
|
|
ANDV
877
CALL
DELISTED
Andeavor
ANDV
| $13.1M | 0.02% |
+249,500
| New | +$14M |
|
878
Murphy Oil
MUR
$5.7B
| $13M | 0.02% |
+247,616
| New | +$13.4M |
|
879
American Eagle Outfitters
AEO
$2.88B
| $13M | 0.02% |
+712,898
| New | +$13.7M |
|
880
Oneok
OKE
$57.2B
| $13M | 0.02% |
+358,557
| New | +$14.7M |
|
|
ARNA
881
PUT
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $13M | 0.02% |
+168,380
| New | +$13.7M |
|
882
PUT
Darden Restaurants
DRI
$23.3B
| $13M | 0.02% |
+287,169
| New | +$13.3M |
|
883
PUT
CVS Health
CVS
$133B
| $12.9M | 0.02% |
+226,400
| New | +$13.1M |
|
884
SPX Corp
SPXC
$11B
| $12.9M | 0.02% |
+712,957
| New | +$13.6M |
|
885
PUT
BioMarin Pharmaceuticals
BMRN
$11.6B
| $12.9M | 0.02% |
+231,400
| New | +$14.4M |
|
886
O-I Glass
OI
$1.1B
| $12.9M | 0.02% |
+463,576
| New | +$12.5M |
|
|
EPB
887
CALL
DELISTED
EL PASO PIPELINE PARTNERS, L.P. COM UNITS REPSTG LTD PART
EPB
| $12.8M | 0.02% |
+292,900
| New | +$12.5M |
|
888
W.W. Grainger
GWW
$65.3B
| $12.8M | 0.02% |
+50,679
| New | +$12.6M |
|
|
EQC
889
DELISTED
Equity Commonwealth
EQC
| $12.8M | 0.02% |
+551,984
| New | +$11.9M |
|
890
Lincoln National
LNC
$8.73B
| $12.8M | 0.02% |
+349,881
| New | +$11.9M |
|
891
iShares Russell 1000 ETF
IWB
$48.3B
| $12.8M | 0.02% |
+141,774
| New | +$12.7M |
|
892
Cardinal Health
CAH
$53.9B
| $12.7M | 0.02% |
+269,820
| New | +$12.3M |
|
893
CALL
Invesco CurrencyShares Australian Dollar Trust
FXA
$97.6M
| $12.7M | 0.02% |
+139,000
| New | +$13.8M |
|
894
PUT
MannKind Corp
MNKD
$1.21B
| $12.7M | 0.02% |
+391,080
| New | +$10.5M |
|
895
CALL
Flowserve
FLS
$9.71B
| $12.7M | 0.02% |
+235,500
| New | +$12.7M |
|
896
Companhia Siderúrgica Nacional
SID
$1.31B
| $12.7M | 0.02% |
+4,574,830
| New | +$16.3M |
|
897
CALL
Lowe's Companies
LOW
$117B
| $12.7M | 0.02% |
+309,500
| New | +$12.5M |
|
|
PXD
898
DELISTED
Pioneer Natural Resource Co.
PXD
| $12.6M | 0.02% |
+87,380
| New | +$11.7M |
|
899
Teradata
TDC
$2.92B
| $12.6M | 0.02% |
+251,034
| New | +$13.5M |
|
900
VF Corp
VFC
$5.63B
| $12.6M | 0.02% |
+276,643
| New | +$11.7M |
|
Similar funds
Barclays's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Barclays, which disclosed 7,700 positions worth $80.4B. Its ten largest holdings account for 27% of the portfolio.
Its largest position is State Street SPDR S&P 500 ETF Trust: 28,286,151 shares worth $4.54B.
By sector, the portfolio is most concentrated in Healthcare at 4.5% of assets, followed by Financials and Technology.
- Barclays's largest Q2 2013 buy was State Street SPDR S&P 500 ETF Trust: 28,286,151 shares worth $4.54B.
- Barclays's ten largest holdings make up 27% of its $80.4B portfolio in Q2 2013.
- Barclays disclosed 7,700 positions in Q2 2013, its first 13F filing on record.
Based on Barclays's 13F filing for Q2 2013, filed 14 Aug 2013.